Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

American businesswoman Anne Wojcicki is the co-founder and CEO of genetic testing company 23andMe. She became a billionaire after the company went public in 2021 but since then, the company’s ...

The North Star at the company, said one former senior leader, is “Is Anne happy?” Amid the board crisis, Wojcicki seems to be doubling down on this approach—a way of leading that Silicon ...

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...

Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her leadership style. “What will be most interesting is writing the story in ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki. The ...

Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration ...